FDA clarifies its approach to biotech animals – May 3, 2024
FDA clarifies its approach to biotech animals The Food and Drug Administration, the lead U.S. regulator of genetically engineered animals, issued two documents to clarify its risk-based oversight of the creatures and their developers. The agency exercises varying levels of scrutiny, ranging from full-scale review of an animal and its… Continue reading